Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA).
Saved in:
| Title: | Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA). |
|---|---|
| Authors: | Kim H; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Na TW; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Jung I; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Kang M; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Park S; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Kwon CH; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea., Jung K; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea. |
| Source: | Biomolecules & therapeutics [Biomol Ther (Seoul)] 2026 May 01; Vol. 34 (3), pp. 578-588. Date of Electronic Publication: 2026 Apr 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Korean Society of Applied Pharmacology Country of Publication: Korea (South) NLM ID: 101472832 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1976-9148 (Print) Linking ISSN: 19769148 NLM ISO Abbreviation: Biomol Ther (Seoul) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42059029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Na+TW%22">Na TW</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+I%22">Jung I</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+M%22">Kang M</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+S%22">Park S</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+CH%22">Kwon CH</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+K%22">Jung K</searchLink>; Pharmacology and Narcotics Research Division, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101472832%22">Biomolecules & therapeutics</searchLink> [Biomol Ther (Seoul)] 2026 May 01; Vol. 34 (3), pp. 578-588. <i>Date of Electronic Publication: </i>2026 Apr 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Society+of+Applied+Pharmacology%22">Korean Society of Applied Pharmacology </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101472832 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1976-9148 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219769148%22">19769148 </searchLink><i>NLM ISO Abbreviation: </i>Biomol Ther (Seoul) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42059029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4062/biomolther.2025.097 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 578 Titles: – TitleFull: Proarrhythmic Risk Assessment of Sildenafil under High-Dose Misuse Conditions Using the Comprehensive In Vitro Proarrhythmia Assay (CiPA). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kim H – PersonEntity: Name: NameFull: Na TW – PersonEntity: Name: NameFull: Jung I – PersonEntity: Name: NameFull: Kang M – PersonEntity: Name: NameFull: Park S – PersonEntity: Name: NameFull: Kwon CH – PersonEntity: Name: NameFull: Jung K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1976-9148 Numbering: – Type: volume Value: 34 – Type: issue Value: 3 Titles: – TitleFull: Biomolecules & therapeutics Type: main |
| ResultId | 1 |